Skip to main content
    N

    Nexalin Technology Inc. (NXL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.56
    +0.08 (+5.41%)

    Market Cap: $1.83M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Nexalin Technology Inc. (NXL) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Nexalin Technology (NXL) is expected to report earnings on Mar 23, 2027. In the quarter ended Sep 30, 2026, Nexalin Technology reported EPS of -$3.43, below the -$2.91 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    22%(2/9)
    Avg Surprise
    -28.63%

    Upcoming Estimates

    Reports Mar 23, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$2.36
    RangeN/A
    2 analysts
    Revenue Consensus
    $90.90K
    Range$88.20K - $94.50K
    2 analysts

    Next Report

    NXL has an expected report date of Mar 23, 2027.

    Earnings History

    Of the 9 quarters below that had an estimate, NXL beat 2 and missed 7. Revenue for the quarter ended Sep 30, 2026 was $78301, up 331.4% from $18149 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$3.43-$2.91-$2.91 - -$2.91-17.87%MissN/A10 up, 0 downNov 12, 2026$78301
    Jun 30, 2026-$0.11-$0.10-$0.10 - -$0.10-10.00%MissN/A10 up, 1 downAug 12, 2026$12161
    Mar 31, 2026-$0.11-$0.12N/A+8.33%BeatN/A11 up, 0 downMay 8, 2026$14950
    Dec 31, 2025-$0.13-$0.12-$0.12 - -$0.12-8.33%MissN/A11 up, 0 downMar 25, 2026$171895
    Sep 30, 2025-$0.13-$0.12-$0.12 - -$0.12-8.33%MissN/A11 up, 0 downNov 14, 2025$18149
    Jun 30, 2025-$0.10-$0.14-$0.14 - -$0.14+28.57%BeatN/A10 up, 1 downAug 6, 2025$70588
    Mar 31, 2025-$0.15-$0.10-$0.10 - -$0.10-50.00%MissN/A11 up, 0 downMay 13, 2025$41015
    Dec 31, 2024-$0.25-$0.12-$0.12 - -$0.12-108.33%MissN/A10 up, 0 downMar 14, 2025$27179
    Sep 30, 2024-$0.23-$0.12-$0.12 - -$0.12-91.67%MissN/A10 up, 0 downNov 8, 2024$36031
    Jun 30, 2024-$0.17N/AN/AN/AN/AN/AN/AN/AAug 8, 2024$26840
    Mar 31, 2024-$4.20N/AN/AN/AN/AN/AN/AN/AMay 10, 2024$78671
    Dec 31, 2023-$3.15N/AN/AN/AN/AN/AN/AN/AMar 27, 2024$20535
    Sep 30, 2023-$9.29N/AN/AN/AN/AN/AN/AN/ANov 13, 2023$24113
    Jun 30, 2023-$3.39N/AN/AN/AN/AN/AN/AN/AAug 10, 2023$35540
    Mar 31, 2023-$0.10N/AN/AN/AN/AN/AN/AN/AMay 10, 2023$30560
    Dec 31, 2022-$0.10N/AN/AN/AN/AN/AN/AN/AMar 2, 2023$38424
    Sep 30, 2022-$0.03N/AN/AN/AN/AN/AN/AN/ANov 10, 2022$545323
    Jun 30, 2022-$0.06N/AN/AN/AN/AN/AN/AN/ASep 19, 2022$414288
    Mar 31, 2022-$0.08N/AN/AN/AN/AN/AN/AN/AJun 29, 2022$323322
    Dec 31, 2021-$0.06N/AN/AN/AN/AN/AN/AN/AMar 30, 2022$23999
    Last 20 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.51, after -$4.85 the year before. It was -$0.06 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.51N/A
    Dec 31, 2024-$4.85N/A
    Dec 31, 2023-$15.93N/A
    Dec 31, 2022-$0.27N/A
    Dec 31, 2021-$0.06N/A

    Frequently Asked Questions About NXL

    When is Nexalin Technology's next earnings date?

    Nexalin Technology's next earnings report is expected for Mar 23, 2027.

    Did NXL beat earnings estimates last quarter?

    No. Nexalin Technology reported EPS of -$3.43 for the quarter ended Sep 30, 2026, below the -$2.91 estimate by 17.87%.

    What EPS do analysts expect from NXL next quarter?

    The consensus EPS estimate for Nexalin Technology for the quarter ending Dec 31, 2026 is -$2.36 from 2 analysts.

    How often does NXL beat earnings estimates?

    Nexalin Technology beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -20.75%.